Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.50
Negar Asdaghi Md Frcpc, Shelagh B. Coutts Md Frcpc
Transient ischemic attack (TIA) and minor stroke (MIS) represent disorders on the same ischemic continuum. It is now well established that these patients are at high risk for early deterioration and recurrent ischemic events. Although clinical characteristics are important for identifying high-risk patients1, the sensitivity of clinical scoring systems in correctly predicting a recurrent event is far from perfect.2 Multiple studies over the past decade have evaluated the ability of modern neuroimaging in isolation3 or in combination with the clinical features in triaging these patients.4, 5
{"title":"Imaging Predictors of Outcome in Patients with Transient Ischemic Attacks and Minor Stroke: Review of published data from the VISION study","authors":"Negar Asdaghi Md Frcpc, Shelagh B. Coutts Md Frcpc","doi":"10.5083/EJCM.20424884.50","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.50","url":null,"abstract":"Transient ischemic attack (TIA) and minor stroke (MIS) represent disorders on the same ischemic continuum. It is now well established that these patients are at high risk for early deterioration and recurrent ischemic events. Although clinical characteristics are important for identifying high-risk patients1, the sensitivity of clinical scoring systems in correctly predicting a recurrent event is far from perfect.2 Multiple studies over the past decade have evaluated the ability of modern neuroimaging in isolation3 or in combination with the clinical features in triaging these patients.4, 5","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.50","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70861110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.51
B. Brembilla-Perrot
lation (PVS) was a major technique of screening patients at risk for ventricular tachycardia (VT) and VT–related sudden death (1-3). During this time PVS was not considered advantageous for risk stratification in coronary heart disease since implantable cardioverter defibrillators (ICD): a number of landmark trials have shown a benefit of prophylactic ICD implantation in patients with only low left ventricular ejection fraction (LVEF) (4,5). Now, the guidelines recommend the systematic implantation of ICD in patients with history of myocardial infarction (MI) (more than 6 weeks) and LVEF lower than 30% (6). However, proarrhythmic effect of ICD and other complications were reported (7-9). More, inducible VT remains an important and independent factor of cardiac mortality (10).
{"title":"Ventricular Stimulation After Myocardial Infarction","authors":"B. Brembilla-Perrot","doi":"10.5083/EJCM.20424884.51","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.51","url":null,"abstract":"lation (PVS) was a major technique of screening patients at risk for ventricular tachycardia (VT) and VT–related sudden death (1-3). During this time PVS was not considered advantageous for risk stratification in coronary heart disease since implantable cardioverter defibrillators (ICD): a number of landmark trials have shown a benefit of prophylactic ICD implantation in patients with only low left ventricular ejection fraction (LVEF) (4,5). Now, the guidelines recommend the systematic implantation of ICD in patients with history of myocardial infarction (MI) (more than 6 weeks) and LVEF lower than 30% (6). However, proarrhythmic effect of ICD and other complications were reported (7-9). More, inducible VT remains an important and independent factor of cardiac mortality (10).","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.51","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70861180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.41
Dm Afscai Arunkumar Panneerselvam Md, D. P. Bhat, Dm Manjunath Cholenahally Nanjappa
{"title":"Coronary Dissection, No Flow, Cardiac Arrest","authors":"Dm Afscai Arunkumar Panneerselvam Md, D. P. Bhat, Dm Manjunath Cholenahally Nanjappa","doi":"10.5083/EJCM.20424884.41","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.41","url":null,"abstract":"","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.41","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70861414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.40
J. Bassand
{"title":"Anticoagulant Therapy in Acute Coronary Syndromes with Focus on Fondaparinux","authors":"J. Bassand","doi":"10.5083/EJCM.20424884.40","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.40","url":null,"abstract":"","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.40","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70860485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.49
J. Boggia, T. Hansen, K. Asayama, L. Luzardo, Yan Li, J. Staessen
In 2002, Thomas G. Pickering wrote, ‘the addition of ambulatory blood pressure monitoring to conventional clinic measurement for defining blood pressure (BP) status in clinical practice has added a new complexity to the process, because the separation of normotension and hypertension can be assessed independently by each of the two methods’[1]. The two groups of patients that arise from this classification and require special attention are individuals with white-coat hypertension and those with masked hypertension. Self measurement of BP at home is increasingly becoming an alternative to ambulatory blood pressure monitoring. The 2007 European Guidelines recommend the same threshold for daytime ambulatory BP monitoring and self measurement of blood pressure (135/85 mmHg).
2002年，Thomas G. Pickering写道:“在常规的临床测量中增加动态血压监测以确定临床实践中的血压(BP)状态，这给这一过程增加了新的复杂性，因为正常血压和高血压的分离可以通过两种方法中的每一种独立评估。”从这种分类中产生并需要特别注意的两组患者是白大褂高血压患者和隐匿性高血压患者。在家自行测量血压正日益成为动态血压监测的一种替代方法。2007年欧洲指南建议，白天动态血压监测和自我血压测量的阈值相同(135/85 mmHg)。
{"title":"White-coat Hypertension on Automated Blood Pressure Measurement: Implications for Clinical Practice","authors":"J. Boggia, T. Hansen, K. Asayama, L. Luzardo, Yan Li, J. Staessen","doi":"10.5083/EJCM.20424884.49","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.49","url":null,"abstract":"In 2002, Thomas G. Pickering wrote, ‘the addition of ambulatory blood pressure monitoring to conventional clinic measurement for defining blood pressure (BP) status in clinical practice has added a new complexity to the process, because the separation of normotension and hypertension can be assessed independently by each of the two methods’[1]. The two groups of patients that arise from this classification and require special attention are individuals with white-coat hypertension and those with masked hypertension. Self measurement of BP at home is increasingly becoming an alternative to ambulatory blood pressure monitoring. The 2007 European Guidelines recommend the same threshold for daytime ambulatory BP monitoring and self measurement of blood pressure (135/85 mmHg).","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.49","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70861383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.44
Malik Asif Humayoun, M. Afzal, T. Waseem, M. Raza, A. Masood, J. Akram
Dr. Malik Asif HumayounMedical Unit 1, Allama Iqbal Medical College/Jinnah HospitalMaulana Shabbir Ahmed Usmani RoadLahore, 54550, PakistanPhone: +92 3336103130Email: doctormalikasif@gmail.com The contribution represents original work, has not been previously published or simultaneously submitted for publication elsewhere. The manuscript has been read and approved by all the authors and that all the ICMJE conditions have been met. The authors have no financial or commercial associations or conflict of interest to declare in relation to submission of this manuscript. ISSN 2042-4884
{"title":"Serum Total Homocysteine Level: A True Cardiovascular Risk Factor or an Acute Phase Reactant Protein?","authors":"Malik Asif Humayoun, M. Afzal, T. Waseem, M. Raza, A. Masood, J. Akram","doi":"10.5083/EJCM.20424884.44","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.44","url":null,"abstract":"Dr. Malik Asif HumayounMedical Unit 1, Allama Iqbal Medical College/Jinnah HospitalMaulana Shabbir Ahmed Usmani RoadLahore, 54550, PakistanPhone: +92 3336103130Email: doctormalikasif@gmail.com The contribution represents original work, has not been previously published or simultaneously submitted for publication elsewhere. The manuscript has been read and approved by all the authors and that all the ICMJE conditions have been met. The authors have no financial or commercial associations or conflict of interest to declare in relation to submission of this manuscript. ISSN 2042-4884","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70861095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-08-01DOI: 10.5083/EJCM.20424884.47
M. Bonis, M. Taramasso, E. Lapenna, O. Alfieri
The 5-year incidence of cardiac death and major cardiac events in asymptomatic severe degenerative MR with medical management is high (14±3% and 33±3%, respectively) 7. Major predictors of poor outcome are advanced age, symptoms of heart failure, pulmonary hypertension, atrial fibrillation, severity of MR, left atrial (LA) and left ventricular (LV) dilatation and depressed LV systolic function.7, 8, 9,10
{"title":"Degenerative Mitral Valve Repair","authors":"M. Bonis, M. Taramasso, E. Lapenna, O. Alfieri","doi":"10.5083/EJCM.20424884.47","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.47","url":null,"abstract":"The 5-year incidence of cardiac death and major cardiac events in asymptomatic severe degenerative MR with medical management is high (14±3% and 33±3%, respectively) 7. Major predictors of poor outcome are advanced age, symptoms of heart failure, pulmonary hypertension, atrial fibrillation, severity of MR, left atrial (LA) and left ventricular (LV) dilatation and depressed LV systolic function.7, 8, 9,10","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.47","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70861265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-02-20DOI: 10.5083/EJCM.20424884.27
J. Ferrer, P. Jiménez-Quevedo, M. Trigo
Despite the development of new anti-ischemic drugs and the improvements in revascularisation techniques, a substantial proportion of patients with ischemic heart disease remain symptomatic with severe debilitating angina. The major aim of therapy for these patients should be aggressive modification of risk factors and optimising medical and interventional treatment. Nevertheless, when disease progresses and standard treatments are not possible, new strategies should be established. In this setting, treatment with peripheral blood-derived stem cells using the transendocardial injection is a new promising option.
{"title":"Treatment of Refractory Angina with Peripheral Blood-derived Stem Cell Using the Transendocardial Injection Route","authors":"J. Ferrer, P. Jiménez-Quevedo, M. Trigo","doi":"10.5083/EJCM.20424884.27","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.27","url":null,"abstract":"Despite the development of new anti-ischemic drugs and the improvements in revascularisation techniques, a substantial proportion of patients with ischemic heart disease remain symptomatic with severe debilitating angina. The major aim of therapy for these patients should be aggressive modification of risk factors and optimising medical and interventional treatment. Nevertheless, when disease progresses and standard treatments are not possible, new strategies should be established. In this setting, treatment with peripheral blood-derived stem cells using the transendocardial injection is a new promising option.","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"213 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.27","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70860855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-02-20DOI: 10.5083/EJCM.20424884.23
P. Vollenweider, G. Waeber, F. Bastardot, M. Preisig
Both cardiovascular diseases (CVD) and mental disorders are major public health issues, which lead to increased disability and mortality. CVD are the worldwide leading cause of death and are responsible for around four million deaths each year in Europe. Mental disorders also demonstrate high lifetime prevalence. For example, the National Comorbidity Survey (NCS), a population-based study in the USA, revealed that as many as 48.7% of the respondents report at least one lifetime disorder, with the most frequent being substance abuse/dependence (35.4%), followed by anxiety (19.2%) and mood disorders (14.7%)[1] reported in European populations[2 3]. A recent WHO projection concluded, that by 2030, unipolar depressive disorders and ischemic heart disease will be among the three leading causes of disease burden worldwide[4].
{"title":"Cardiovascular Diseases and Mental Disorders: Bidirectional Risk Factors?","authors":"P. Vollenweider, G. Waeber, F. Bastardot, M. Preisig","doi":"10.5083/EJCM.20424884.23","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.23","url":null,"abstract":"Both cardiovascular diseases (CVD) and mental disorders are major public health issues, which lead to increased disability and mortality. CVD are the worldwide leading cause of death and are responsible for around four million deaths each year in Europe. Mental disorders also demonstrate high lifetime prevalence. For example, the National Comorbidity Survey (NCS), a population-based study in the USA, revealed that as many as 48.7% of the respondents report at least one lifetime disorder, with the most frequent being substance abuse/dependence (35.4%), followed by anxiety (19.2%) and mood disorders (14.7%)[1] reported in European populations[2 3]. A recent WHO projection concluded, that by 2030, unipolar depressive disorders and ischemic heart disease will be among the three leading causes of disease burden worldwide[4].","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.23","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70860926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-02-20DOI: 10.5083/EJCM.20424884.33
E. Sbarouni, P. Georgiadou, V. Voudris
{"title":"Ischemia Modified Albumin as an Acute-Phase Reactant","authors":"E. Sbarouni, P. Georgiadou, V. Voudris","doi":"10.5083/EJCM.20424884.33","DOIUrl":"https://doi.org/10.5083/EJCM.20424884.33","url":null,"abstract":"","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.33","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70860636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：